<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Kidney Cancer

Community    Prostate Cancer    Bladder Cancer    Kidney Cancer    Testicular cancer

CU Cancer Center Member Helps Develop Genitourinary Cancer Guidelines in Sub-Saharan Africa 

It’s one thing to develop cancer treatment guidelines in the U.S., where even the smallest health centers have access to the same basic technology for treatment and testing. But what about creating guidelines for oncologists in Sub-Saharan Africa, where access to medical resources can be limited and the disease can present differently?  


Author Greg Glasgow | Publish Date June 07, 2023
Full Story

Patient Care    Community    Kidney Cancer    Urology

Kidney Cancer Journey Emphasizes Importance of Asking a Doctor when Things Don’t Feel Right

 

To start with, there was his usual schedule of national travel for his job as a Wall Street journeyman – he was always flying somewhere. Add to that moving to Castle Rock from San Francisco, plus a love for concerts and baseball games and whatever else life offers, and it’s no wonder that Lincoln Yersin was feeling run down.

But this run down? This exhausted? He went to see his primary care provider in San Francisco a few times, had a few tests, and the diagnosis was stress.


Author Rachel Sauer | Publish Date May 16, 2023
Full Story

Research    Pediatric Cancer    Kidney Cancer    Urology

Research Shows that Lymph Node Sampling During Kidney Tumor Surgery Is Safe

A longstanding approach to surgeries for children with kidney tumors has been an abundance of caution.


Author Rachel Sauer | Publish Date April 26, 2023
Full Story

Kidney Cancer    Urology

Ronnie Hillman’s Death Highlights Rare Cancer that Disproportionately Affects Young Black Men

Former Denver Broncos running back Ronnie Hillman, 31, died Wednesday of a rare type of kidney cancer that disproportionately impacts young people who are Black with sickle cell trait or sickle cell disease.


Author Rachel Sauer | Publish Date December 22, 2022
Full Story

Research    Community    Kidney Cancer   

5 Things to Know About Kidney Cancer 

March is Kidney Cancer Awareness Month, and to get the latest information on the disease, we spoke with University of Colorado (CU) Cancer Center member Elaine Lam, MD, FACP, an associate professor of medicine in the Division of Medical Oncology at the University of Colorado School of Medicine


Author Greg Glasgow | Publish Date March 02, 2022
Full Story

Research    Awareness    Pediatric Cancer    Kidney Cancer

Research supports the practice of personalized treatment to improve fertility outcomes for pediatric kidney cancer patients

Although rare, kidney cancer is the third most common type of solid tumor affecting children. Thankfully, pediatric kidney tumors are generally treatable and most have high cure rates. Treatment outcomes depend on several factors including age, tumor type, staging, genetics, the overall health of the patient, and the risk of treatment side effects.  


Author Noelle Musgrave | Publish Date April 09, 2021
Full Story

CU Cancer Center In the News

OncLive

The Role of mTOR/Aurora A Kinase Combination Therapy Requires Further Elucidation in Solid Tumors

news outletOncLive
Publish DateJuly 08, 2024

CU Cancer Center member S. Lindsey Davis, MD, highlighted that the combination therapy of sapanisertib and alisertib showed marginal clinical benefit for patients with advanced solid tumors, correlative analyses suggested that apoptotic response and tumor immune cell infiltrate might influence clinical outcomes. The phase 1b study's expansion cohort indicated some positive outlying responses among patients and underscore the need for further research to tailor treatments for standout patients and explore rational combinations to enhance efficacy.

Full Story
News Medical

Study shows effectiveness of treating pancreatic cancer patients with chemotherapy before surgery

news outletNews Medical
Publish DateJune 19, 2024

A new study led by University of Colorado Cancer Center member Marco Del Chiaro, MD, PhD, reveals that nearly 5% of pancreatic adenocarcinoma patients achieved a pathological complete response (pCR) after pre-surgical chemotherapy or chemoradiotherapy. This significant finding indicates that patients with pCR have a 63% five-year survival rate, compared to 30% for those without pCR, suggesting the potential for tailored treatments to improve outcomes.

Full Story
Cancer Network

Liso-cel May Show Benefit in Earlier Therapy Lines for Lymphoma Subgroups

news outletCancer Network
Publish DateJune 14, 2024

In a conversation at the 2024 European Hematology Association Congress, CU Cancer Center member Manali Kamdar, MD, discussed potential future research on lisocabtagene maraleucel (liso-cel; Breyanzi) for mantle cell lymphoma (MCL) and other lymphoma subgroups. She highlighted findings from the phase 1 TRANSCEND NHL 001 trial, noting improved efficacy and safety in patients with fewer prior therapies and non-refractory disease, suggesting liso-cel's utility in earlier treatment lines and specific lymphoma subgroups.

Full Story
Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story